Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    22648957 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Effects of Intranasal Administration of a Single Dose of Oxytocin Using a Novel Device in Healthy Adults
Condition: Healthy Male Adults
Interventions: Drug: 8IU intranasal oxytocin;   Drug: 24 IU intranasal oxytocin;   Drug: 1 IU intravenous oxytocin;   Drug: Placebo

Indicates status has not been verified in more than two years